Evonik has made a follow-up investment in the biotechnology start-up In Ovo through its venture capital unit. The investment comes as the young company reaches the commercialization stage for its technology and is bringing its gender-testing machine for eggs to the market.
- Start-up reaches commercialization stage for its technology
- Fast and reliable gender determination of chicken embryos in the egg now possible at scale
- Technology enables egg producers to avoid killing of male chicks, which is prohibited from 2022 in Germany
For the full press release click here.